Nabriva Therapeutics (NBRVF) Q4 2021 Earnings

29MarExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.67
-0.51
-0.35
-0.19

Details

Expected EPS
-0.19
Actual EPS
-0.24
Surprise EPS
-0.05
Surprise Percent
+26.32%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.24 per share for Q4 2021.

0 Comments

Share your thoughts